Close the acquisition of Chronix Biomedical
Delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 3 Feb 2021
- Due
- 30 Apr 2021
- Delivered
- 15 Apr 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“The closing of the merger is subject to a number of conditions, including approval of the transaction by Chronix shareholders, and is expected to be completed by April 30, 2021.”
What we found
Evidence strength A What the grades mean
OncoCyte completed the acquisition of Chronix Biomedical on April 15, 2021, which is before the stated deadline of April 30, 2021.
-
A OncoCyte Corp 10-Q filed 2021-08-11
“On April 15, 2021, the Chronix Merger Date, Oncocyte completed its acquisition of Chronix pursuant the Chronix Merger Agreement.” ✓ confirmed on the page
Checked 25 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Acquisition close
- Indicative materiality
- High rules
- Action
- Close
- Deliverable
- Acquisition of Chronix Biomedical
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- Medium
- Specificity
- High
- Conditional
- Yes: approval of the transaction by Chronix shareholders
- Depends on
- Shareholder
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you OncoCyte Corp? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-IMDX-023020 · Corrections policy